Clinical trial
Hepatitis B Vaccination in HIV-infected Persons
NCT00230061 · Erasmus Medical Center, Other · Completed
Key facts
| NCT number | NCT00230061 |
|---|---|
| Title | Hepatitis B Vaccination in HIV-infected Persons |
| Official title | Randomised Open Label Clinical Trial of the Immune Response to Hepatitis B Vaccination in HIV-infected Persons. |
| Lead sponsor | Erasmus Medical Center, Other |
| Collaborators | Stichting Nuts Ohra |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatitis B |
| Intervention type | Biological |
| Interventions | HBVAXPRO, Hepatitis B (Recombinant) vaccine, 10 mcg/ml |
| Enrollment | 800 |
| Start date | Apr 1, 2004 |
| Primary completion | May 1, 2008 |
| Completion | Feb 1, 2010 |
| First posted | Sep 30, 2005 |
| Last update posted | Jun 2, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: